There is evidence that in diseases of chronic inflammation, such as systemic lupus erythematosus (SLE), PSGL-1 signaling works to suppress inflammation, as Selplg−/− mice with SLE suffer more inflammation and early death (170). This evidence concerns the gene SELPLG and inflammatory response.